Permission was obtained from the Ministry of Health for the center to participate in a clinical trial of a new form of tocilizumab for patients with rheumatoid arthritis.

A selection visit was successfully completed to participate in a clinical trial of a biological therapy drug for the treatment of plaque psoriasis.

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen